Reimbursed Telemonitoring for Chronic Heart Failure
Telemonitoring for chronic heart failure has become an integral part
of reimbursed healthcare in Germany, with statutory health insurance covering these services since
January 2022. This initiative aims to enhance patient care by enabling continuous remote monitoring,
reducing hospitalizations, and improving outcomes for individuals with CHF.
Eligibility Criteria
for Telemonitoring
To qualify for telemonitoring services, patients must meet the following conditions:
NYHA Class II or III:
Moderate to severe heart failure classification.
Reduced Left Ventricular Ejection Fraction (LVEF < 40%):
Indicating significant heart dysfunction.
Recent Hospitalization or Implanted Device:
– Hospital admission for heart failure decompensation within the last 12 months.
– The presence of an implanted cardiac device, such as an Implantable
Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy Device (CRT-P or CRT-D).
Patient Capability:
Cognitive and physical ability to handle the telemonitoring process and use the required equipment effectively.
Implementation Considerations:
To offer telemonitoring services, healthcare providers must:
The integration of telemonitoring into routine care represents a significant advancement in managing chronic heart failure in Germany, offering continuous patient monitoring and timely interventions to improve health outcomes.
Obtain Certification as a Telemedicine Center (TMZ):
Approval is required from the Association of Statutory Health Insurance Physicians (KV).
Utilize Approved Telemonitoring Software:
Ensure compatibility with required data transmission and security standards.
Provide External Measuring Devices:
Supply patients with devices such as scales, blood pressure monitors, and ECG equipment for daily monitoring.
Leveraging Predictive Analytics for Patient Care
Utilizing the power of AI and machine learning, Docs4D HCP analyzes vast amounts of health data in real-time, identifying patterns and anomalies that may indicate the onset of complications. This allows healthcare providers to intervene early, adjust treatment plans, and implement preventive measures, significantly improving patient outcomes.
Benefits of Telemedicine
Telemedicine has demonstrated significant benefits in managing chronic heart failure,
including reductions in patient mortality, unplanned hospital admissions, and high patient compliance rates.
Reduction in Patient Mortality:
Up to 35% reduction in mortality
The IN-TIME study evaluated the impact of automatic multiparameter telemonitoring on patients with heart failure equipped with an Implantable Cardioverter Defibrillator (ICD) or Cardiac Resynchronization Therapy Defibrillator (CRT-D). The study found a significant reduction in mortality among patients receiving telemonitoring compared to those receiving standard care.
Reduction of Unplanned Admissions:Up to 30% reduction admissions
The TIM-HF2 trial assessed the effectiveness of remote patient management in heart failure patients. Results indicated a 20% reduction in days lost due to unplanned cardiovascular hospital admissions or all-cause death during a one-year follow-up period
Extrabudgetary Reimbursement
Remote Patient Monitoring (RPM) with external measuring devices is reimbursed nationwide and falls outside of budget restrictions—no upfront costs for you.
PER PATIENT PER QUARTER
Instruction of the patient in telemonitoring GOP 13583
€10.70
Device lump sum: GOP 40910
€68
Telemonitoring, communication with the attending physician: GOP 13584 and GOP 13586
€236.59
Surcharge for intensified telemonitoring on weekends and holidays: GOP 13585 and 13587
€6.99 / €7.58
GOÄ REMUNERATION PER PATIENT
Telemedicine remote monitoring GOÄ 653
€177.00 (Weekly) Information
Quarterly report (automated) GOÄ 75
€7.58 (Per quarter) Information
Evaluation intensive profile GOÄ 60
€26.99 (Per quarter)
Reaction to alarm GOÄ 60/75
€6.99 / €7.58
English 
German 
French 
Greek 